Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Roof who wrote (1265)	3/5/1999 12:15:00 PM
From: mesaone	Read Replies (1) of 1432

Jim, It will be interesting to see what happens next week when the rights offering ends. Everyone that I know have been oversubscribing, and from what I understand one of the biggest reasons that BTIM set up the offering is because the insiders all want to buy a lot more stock. I also understand that they have hired a pr firm :-) to position them. The 2.1 million shorts are between scylla and charybdis, and FDA approval is very near. My guess is that we get approval before the end of March. Biotime is going to push for the best possible labelling they can get on Hextend, and Abbott is very excited about the product. This is going to be fun. inch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next